Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.W | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by vestor111on Jul 10, 2020 7:54am
113 Views
Post# 31250053

RE:RE:RE:Anonymous = Pharma??????????????

RE:RE:RE:Anonymous = Pharma??????????????The compound cannot be taken on to the market without TLT's say so Fred.   Geez stop handwringing this.   This is great news.   Parallel efforts. 

Arguably helping to build knowledge of the compound and what it is potentially capable of... and then there is "Right to Try"  which could over time create demand pull.

Make no mistake, TLT has the worldwide rights to the compound and Dr Sherri is helping raise awareness. 

And Rutherrin is TLT's patent.  Nothing can change that if you think somehow mistakenly think Dr Sherri would try to pull her patents away - somehow.

Ain't happening.  So stop. Geez.
<< Previous
Bullboard Posts
Next >>